AU2003206424A1 - Sequential estrogen/progesterone antagonist combination for hormone replacement therapy - Google Patents

Sequential estrogen/progesterone antagonist combination for hormone replacement therapy

Info

Publication number
AU2003206424A1
AU2003206424A1 AU2003206424A AU2003206424A AU2003206424A1 AU 2003206424 A1 AU2003206424 A1 AU 2003206424A1 AU 2003206424 A AU2003206424 A AU 2003206424A AU 2003206424 A AU2003206424 A AU 2003206424A AU 2003206424 A1 AU2003206424 A1 AU 2003206424A1
Authority
AU
Australia
Prior art keywords
replacement therapy
hormone replacement
antagonist combination
progesterone antagonist
sequential estrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2003206424A
Other versions
AU2003206424B2 (en
Inventor
Kristof Chwalisz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU59427/00A external-priority patent/AU5942700A/en
Application filed by Schering AG filed Critical Schering AG
Priority to AU2003206424A priority Critical patent/AU2003206424B2/en
Publication of AU2003206424A1 publication Critical patent/AU2003206424A1/en
Application granted granted Critical
Publication of AU2003206424B2 publication Critical patent/AU2003206424B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2003206424A 1996-03-11 2003-07-02 Sequential estrogen/progesterone antagonist combination for hormone replacement therapy Ceased AU2003206424B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003206424A AU2003206424B2 (en) 1996-03-11 2003-07-02 Sequential estrogen/progesterone antagonist combination for hormone replacement therapy

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19610635 1996-03-11
AU59427/00A AU5942700A (en) 1996-03-11 2000-09-14 Sequential estrogen/progestrone antagonist combination for hormone replacement theapy
AU2003206424A AU2003206424B2 (en) 1996-03-11 2003-07-02 Sequential estrogen/progesterone antagonist combination for hormone replacement therapy

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU59427/00A Division AU5942700A (en) 1996-03-11 2000-09-14 Sequential estrogen/progestrone antagonist combination for hormone replacement theapy

Publications (2)

Publication Number Publication Date
AU2003206424A1 true AU2003206424A1 (en) 2003-07-24
AU2003206424B2 AU2003206424B2 (en) 2006-04-27

Family

ID=3744622

Family Applications (2)

Application Number Title Priority Date Filing Date
AU59427/00A Abandoned AU5942700A (en) 1996-03-11 2000-09-14 Sequential estrogen/progestrone antagonist combination for hormone replacement theapy
AU2003206424A Ceased AU2003206424B2 (en) 1996-03-11 2003-07-02 Sequential estrogen/progesterone antagonist combination for hormone replacement therapy

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU59427/00A Abandoned AU5942700A (en) 1996-03-11 2000-09-14 Sequential estrogen/progestrone antagonist combination for hormone replacement theapy

Country Status (1)

Country Link
AU (2) AU5942700A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468736A (en) * 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy

Similar Documents

Publication Publication Date Title
GB2320190B (en) Total hormone replacement therapy
AU1892097A (en) Estrogenic agents
AU1892197A (en) Estrogenic agents
AU4557099A (en) Novel therapeutic agents that modulate estrogen receptors
HUP9900301A3 (en) Hormone patch
AU5165193A (en) Human steroid hormone receptor neri
AU4091696A (en) Estrogen agonists/antagonists
HUP9700636A3 (en) Novel estrogen receptor
EP1143948A3 (en) Liver-selective glucocorticoid antagonist for treating diabetes
AU4041295A (en) Estrogen agonists
PL345588A1 (en) Use of biogenic estrogen sulfamates for hormone replacement therapy
AU3350697A (en) Steroid bisphosphonates
AU3223397A (en) Specific co-activator for human androgen receptor
AU5315096A (en) 19-oxygenated steroids as therapeutic agents
AU3556199A (en) Improved methods for making hormone heterodimers
EP0889051A4 (en) Triterpene derivatives and remedies for liver diseases
AU3888697A (en) Progestin/estrogen oral contraceptive
AU3388597A (en) Human type ii gonadotropin-releasing hormone receptor
NZ294508A (en) Androstane derivatives
AU9001698A (en) Remedies for hormone-dependent diseases
HUP9901474A3 (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
GB9616700D0 (en) Hormone supplement
AU2003206424A1 (en) Sequential estrogen/progesterone antagonist combination for hormone replacement therapy
AU1400597A (en) Dispenser for a therapeutic substance
AU9762098A (en) Steroid hormone binding protein